fbpx

CEO Matt Handel interviewed by CEO/CFO Magazine about the company’s growth, its first US Patent and plans for future expansion

Read Full Article Here

 


Better Knock-ins, Better Cell Lines, Better Science

ExpressCells leverages proprietary gene-editing tools to customize human cell lines for drug discovery, toxicology, and other biologic research.

Contact Us

This field is for validation purposes and should be left unchanged.

Pin It on Pinterest